Interventional treatments impact opioid use
A 7-month retrospective analysis compared opioid use and hospital visits for 8,845 VCF patients before and after a balloon kyphoplasty (BKP) or vertebroplasty (VP) procedure. Findings for these BKP/VP patients showed:
A 7-month retrospective healthcare claims analysis using the Truven database, coauthored by physicians and Medtronic health economics employees, analyzed the impact of opioid prescription fills on medical visits, opioid usage, and prescription costs in patients with vertebral compression fracture (VCF).
Patient claims were followed from the second month to the seventh month after respective BKP or VP procedure discharge dates.
decreased or discontinued opioid use after 7 months follow-up among patients with any opioid use pre- and/or post-surgery.1
For patients who decreased or discontinued opioid use:
Average number of treated days in the 2 months prior to surgery was
versus 9.7 in the 2-month post-washout1
Average daily MME in
the 2 months prior to
decreased to zero in follow-up1
There were significantly reduced average all-cause payer costs after
in follow-up compared to baseline1
Balloon kyphoplasty indication and risk statements
Kyphon™ Balloon Kyphoplasty is a minimally invasive procedure for the treatment of pathological fractures of the vertebral body due to osteoporosis, cancer, or benign lesion. Cancer includes multiple myeloma and metastatic lesions, including those arising from breast or lung cancer, or lymphoma. Benign lesions include hemangioma and giant cell tumor.
The overall complication rate with the procedure has been demonstrated to be low. Risks of acrylic bone cements include cement leakage, which may cause tissue damage, nerve or circulatory problems, and other serious adverse events, such as: cardiac arrest, cerebrovascular accident, myocardial infarction, pulmonary embolism, cardiac embolism.
For complete information regarding indications for use, contraindications, warnings, precautions, adverse events, and methods of use, please reference the devices’ Instructions for Use included with the product.
Medtronic offers multiple vertebral augmentation options. See the portfolio, and the clinical evidence that drives innovation.
*Third party brands are trademarks of their respective owners.
Ni W, Ricker C, Quinn M, Gasquet N, Janardhanan D, Gilligan CJ, Hirsch JA. Trends in opioid use following balloon kyphoplasty or vertebroplasty for the treatment of vertebral compression fractures. Osteoporos Int. 2021 doi: 10.1007/s00198-021-06163-3. Epub ahead of print. PMID: 34729624.